09.02.2013 Views

Bulletin 2009/49 - European Patent Office

Bulletin 2009/49 - European Patent Office

Bulletin 2009/49 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(A61K) I.1(1)<br />

(71) IRM LLC, 131 Front Street PO Box HM 2899,<br />

Hamilton HM LX, BM<br />

The Scripps Research Institute, 10550 North<br />

Torrey Pines Road, La Jolla, CA 92037, US<br />

(72) WINZELER, Elizabeth, San Diego, California<br />

92130, US<br />

GRAY, Nathanael S., Boston, Massachusetts<br />

02130, US<br />

HAN, Dong, San Diego, California 92014, US<br />

CHENG, Dai, San Diego, California 92126,<br />

US<br />

(74) Kiddle, Simon John, et al, Mewburn Ellis LLP<br />

33 Gutter Lane, London EC2V 8AS, GB<br />

A61K 31/52 → (51) C07D 471/04<br />

A61K 31/52 → (51) C07D 473/34<br />

(51) A61K 31/53 (11) 2 124 955 A2*<br />

G01N 33/573 G01N 33/68<br />

A61P 9/04 A61P 9/10<br />

A61P 9/12<br />

(25) De (26) De<br />

(21) 07818641.8 (22) 02.10.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(86) EP 2007/008561 02.10.2007<br />

(87) WO 2008/043461 2008/16 17.04.2008<br />

(88) 28.08.2008<br />

(30) 14.10.2006 DE 102006048693<br />

(54) • INHIBITION DER PDE2A<br />

• INHIBITION OF PDE2A<br />

• INHIBITION DE LA PDE2A<br />

(71) Bayer Schering Pharma Aktiengesellschaft,<br />

Müllerstrasse 178, 13353 Berlin, DE<br />

(72) ELLINGHAUS, Peter, 42113 Wuppertal, DE<br />

WILMEN, Andreas, 50676 Köln, DE<br />

HENDRIX, Martin, 51519 Odenthal, DE<br />

TERSTEEGEN, Adrian, 42111 Wuppertal, DE<br />

A61K 31/53 → (51) A61K 45/06<br />

A61K 31/53 → (51) C07D 487/04<br />

A61K 31/535 → (51) C07C 311/37<br />

A61K 31/5355 → (51) C07D 487/02<br />

A61K 31/5365 → (51) C07D 487/02<br />

A61K 31/5375 → (51) A61K 31/135<br />

A61K 31/5375 → (51) C07D <strong>49</strong>8/04<br />

A61K 31/5377 → (51) A61K 31/52<br />

A61K 31/5377 → (51) C07D 211/16<br />

A61K 31/5377 → (51) C07D 217/24<br />

A61K 31/5383 → (51) C07D <strong>49</strong>8/04<br />

(51) A61K 31/5415 (11) 2 124 956 A1*<br />

A61P 13/00<br />

(25) Fr (26) Fr<br />

(21) 07858150.1 (22) 26.12.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 2007/064553 26.12.2007<br />

(87) WO 2008/080924 2008/28 10.07.2008<br />

(30) 28.12.2006 FR 0656002<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(54) • VERWENDUNG VON 10-[(3R)-1-AZABI-<br />

CYCLO[2.2.2]OCT-3-YLMETHYL]-10H-<br />

PHENOTHIAZIN FÜR DIE ZUBEREITUNG<br />

EINES WIRKSTOFFES MIT SELEKTIVER<br />

HEMMUNG DER MUSKARIN-REZEPT-<br />

OREN M1, M2 UND M3<br />

• USE OF 10-[(3R)-1-AZABICYCLO[2.2.2]<br />

OCT-3-YLMETHYL]-10H-PHENOTHIAZINE<br />

FOR THE PREPARATION OF A DRUG<br />

HAVING A SELECTIVE INHIBITION OF<br />

MUSCARINIC M1, M2 AND M3 RECEP-<br />

TORS<br />

• UTILISATION DU 10-[(3R)-1-AZABICY-<br />

CLO]2.2.2]OCT-3-YLMÉTHYL]-10H-PHÉ-<br />

NOTHIAZINE POUR LA PRÉPARATION<br />

D'UN MÉDICAMENT EXERÇANT UNE<br />

INHIBITION SÉLECTIVE DES RÉCEPTEURS<br />

MUSCARINIQUES M1, M2 ET M3<br />

(71) Pierre Fabre Medicament, 45 Place Abel<br />

Gance, 92100 Boulogne-Billancourt, FR<br />

(72) CLERC, Thierry, F-31320 Vigoulet Auzil, FR<br />

TISNE-VERSAILLES, Jacky, F-81100 Castres,<br />

FR<br />

PRZYBYLSKI, Christophe, F-31290 Villefranche<br />

De Lauragais, FR<br />

(74) Ahner, Francis, et al, Cabinet Régimbeau 20,<br />

rue de Chazelles, 75847 Paris cedex 17, FR<br />

A61K 31/545 → (51) A61K 9/08<br />

A61K 31/545 → (51) A61K 31/403<br />

A61K 31/546 → (51) A61K 31/403<br />

A61K 31/55 → (51) A01N 43/00<br />

A61K 31/55 → (51) A61K 31/135<br />

A61K 31/55 → (51) A61K 31/52<br />

A61K 31/551 → (51) A61K 31/506<br />

A61K 31/5513 → (51) A61K 31/52<br />

A61K 31/553 → (51) A61K 31/52<br />

(51) A61K 31/554 (11) 2 124 957 A1*<br />

(25) En (26) En<br />

(21) 08732646.8 (22) 21.03.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(86) US 2008/057808 21.03.2008<br />

(87) WO 2008/116144 2008/39 25.09.2008<br />

(30) 22.03.2007 US 896481 P<br />

(54) • VERFAHREN ZUR BEHANDLUNG VON<br />

GEMÜTSERKRANKUNGEN<br />

• METHODS OF TREATING MOOD DISOR-<br />

DERS<br />

• PROCÉDÉS DE TRAITEMENT DE TROU-<br />

BLES DE L'HUMEUR<br />

(71) AstraZeneca AB, Global Intellectual Property,<br />

151 85 Södertälje, SE<br />

(72) CHRISTOPH, Greg, Wilmington, DE 19850-<br />

5437, US<br />

GRIMM, Scott, W., Wilmington, DE 19850-<br />

5437, US<br />

WIDZOWSKI, Dan, Wilmington, DE 19850-<br />

5437, US<br />

(74) Sternas, Ann-Sofie, et al, AstraZeneca AB<br />

Global Intellectual Property, <strong>Patent</strong>s, 151 85<br />

Södertälje, SE<br />

A61K 31/555 → (51) A61K 9/08<br />

A61K 31/557 → (51) A61K 9/00<br />

A61K 31/557 → (51) A61K 39/106<br />

75<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>49</strong>/<strong>2009</strong>) 02.12.<strong>2009</strong><br />

(51) A61K 31/56 (11) 2 124 958 A2*<br />

(25) En (26) En<br />

(21) 07865244.3 (22) 05.12.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(86) US 2007/086517 05.12.2007<br />

(87) WO 2008/070728 2008/24 12.06.2008<br />

(88) 07.08.2008<br />

(30) 05.12.2006 US 634347<br />

(54) • BEHANDLUNG FÜR TROCKENEN AUGEN<br />

MITTELS TESTOSTERON UND PROGES-<br />

TAGEN<br />

• TREATMENT FOR DRY EYE USING TES-<br />

TOSTERONE AND PROGESTAGEN<br />

• TRAITEMENT DU SYNDROME DE L' IL<br />

SEC EN EMPLOYANT UNE TESTOSTÉ-<br />

RONE ET UNE PROGESTAGÈNE<br />

(71) Southern College Of Optometry, 1245 Madison<br />

Avenue, Memphis TN 38104, US<br />

(72) CONNOR, Charles G., Germantown, TN<br />

38138, US<br />

HAINE, Charles, Memphis, TN 38104, US<br />

(74) Duckett, Anthony Joseph, et al, Mathys &<br />

Squire LLP 120 Holborn, London EC1N 2SQ,<br />

GB<br />

A61K 31/565 → (51) A61K 31/203<br />

A61K 31/566 → (51) A61K 31/203<br />

A61K 31/567 → (51) A61K 31/203<br />

(51) A61K 31/569 (11) 2 124 959 A1*<br />

A61K 9/14 A61P 9/12<br />

(25) En (26) En<br />

(21) 07845436.0 (22) 21.12.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(86) AU 2007/001998 21.12.2007<br />

(87) WO 2008/074098 2008/26 26.06.2008<br />

(30) 21.12.2006 AU 2006907173<br />

(54) • PHARMAZEUTISCHE ZUSAMMENSET-<br />

ZUNG<br />

• PHARMACEUTICAL COMPOSITION<br />

• COMPOSITION PHARMACEUTIQUE<br />

(71) Alphapharm PTY LTD, 15 Garnet Street,<br />

Carole Park, QLD 4300, AU<br />

Generics (UK) Limited, Albany Gate Darkes<br />

Lanes, Potters Bar, Hertfordshire EN6 1AG,<br />

GB<br />

(72) MOONEY, Brett Antony, Mt Ommaney,<br />

Queensland 4074, AU<br />

OWUSU-GYAMFI, Erwin, Potters Bar Hertfordshire<br />

EN6 1AG, GB<br />

(74) Faivre Petit, Frédérique, et al, Cabinet<br />

Regimbeau 20, rue de Chazelles, 75847 Paris<br />

Cedex 17, FR<br />

A61K 31/569 → (51) A61K 31/203<br />

(51) A61K 31/57 (11) 2 124 960 A1*<br />

A61K 8/63 A61P 17/00<br />

A61P 17/08 A61P 17/10<br />

A61P 17/14<br />

(25) De (26) De<br />

(21) 07856867.2 (22) 19.12.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(86) EP 2007/011144 19.12.2007<br />

(87) WO 2008/077542 2008/27 03.07.2008<br />

(30) 22.12.2006 DE 102006062120<br />

(54) • 3-HYDROXY-CHLORMADINONACETAT<br />

ZUR TOPISCHEN BEHANDLUNG VON<br />

ANDROGEN-ABHÄNGIGEN HAUTERKRAN-<br />

KUNGEN

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!